EUVIMEDEUVIMED entdecken
Crossref

Surgical Outcomes in Patients with Endolymphatic Sac Tumors: A Single‐Center Experience of 29 Patients

Yuanyuan Yang iD, Feitian Li iD, Mengye Ma, Chunfu Dai iD

The Laryngoscope · 2024

DOI: 10.1002/lary.31711 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, 2024. Verfasst von Yuanyuan Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otology and Skull Base Surgery, Eye, Ear, Nose, and Throat Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Endolymphatic Sac, Ear Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shenzhen High-level Hospital Construction Fund, Shanghai Municipal Key Clinical Specialty.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To analyze the clinical features and surgical outcomes of patients with endolymphatic sac tumors (ELSTs). Study Design Single institution retrospective cohort study.

Methods

The clinical data of 29 patients with 30 ELSTs who underwent surgery were retrospectively reviewed. Information on patient demographics, tumor size and grade, intraoperative blood loss volume, hearing and facial nerve outcomes, and follow‐up data was collected and analyzed.

Results

The main symptoms were hearing loss in 26 ELSTs (86.7%) and tinnitus in 17 (56.7%). Twenty‐four (80%) ELSTs were in advanced stages (Grade III). The median tumor volume was 6.35 cm 3 . The median intraoperative blood loss volume was 300 mL. Facial nerve function was well preserved in 21 patients. Among all patients with Grade III tumors, 12 patients underwent tension‐free anterior facial nerve rerouting, and 11 patients (91.7%) maintained good facial nerve function postoperatively (HB I and HB II). Only one patient exhibited permanent vocal cord paralysis, and no patients experienced cerebrospinal fluid (CSF) leakage postoperatively. Gross total resection was achieved in 22 patients (73.3%), 5 patients (16.7%) experienced tumor recurrence, and 3 (10%) had residual tumors.

Conclusions

Most ELSTs tend to be diagnosed in the advanced stage. Tension‐free anterior facial nerve rerouting could maximally preserve facial nerve function. The intraoperative blood loss volume was associated with tumor size and stage. Tumor recurrence tends to occur at the posterior edge of the petrosal bone, internal auditory canal, and surface of the posterior fossa. Given the relatively high recurrence rate of ELSTs, long‐term follow‐up is recommended. Level of Evidence 4 Laryngoscope , 2024

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endolymphatic SacEar NeoplasmsHumansMaleFemaleRetrospective StudiesMiddle AgedAdultTreatment OutcomeAgedYoung AdultAdolescentBlood Loss, SurgicalHearing Loss

Stichwörter der Autor:innen

Von Hippel–Lindau (VHL)endolymphatic sac tumorstemporal bone tumor

Autor:innen und Institutionen

  • Department of Otology and Skull Base Surgery, Eye, Ear, Nose, and Throat Hospital, Fudan University, Shanghai, China.
  • Key Laboratory of Hearing Medicine, Ministry of Health, Eye, Ear, Nose, and Throat Hospital, Fudan University, Shanghai, China.
  • Department of Otolaryngology, Peking University Shenzhen Hospital, Shenzhen, China.

ORCID-Profile: Yuanyuan Yang, Feitian Li, Chunfu Dai

Förderung

  • National Natural Science Foundation of China
  • Shenzhen High-level Hospital Construction Fund
  • Shanghai Municipal Key Clinical Specialty

Zitieren

APA

Yang, Y., Li, F., Ma, M., & Dai, C. (2024). Surgical Outcomes in Patients with Endolymphatic Sac Tumors: A Single‐Center Experience of 29 Patients. The Laryngoscope. https://doi.org/10.1002/lary.31711

Vancouver

Yang Y, Li F, Ma M, Dai C. Surgical Outcomes in Patients with Endolymphatic Sac Tumors: A Single‐Center Experience of 29 Patients. The Laryngoscope. 2024. doi:10.1002/lary.31711

BibTeX
@article{Yang2024,
  author = {Yang, Yuanyuan and Li, Feitian and Ma, Mengye and Dai, Chunfu},
  title = {Surgical Outcomes in Patients with Endolymphatic Sac Tumors: A Single‐Center Experience of 29 Patients},
  journal = {The Laryngoscope},
  year = {2024},
  doi = {10.1002/lary.31711}
}
Kostenlos starten →